OOIR: Observatory of International Research

Papers

(The TQCC of Journal of the American College of Cardiology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Long-Duration Space Flight and Cardiac Morphology	2263
Shining a New Light Into the Black Box	1909
GENDER DIFFERENCES IN REFERRAL PATTERNS FOR EVALUATION OF STABLE CORONARY ARTERY DISEASE (CAD) BY CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY (CCTA)	1297
THE IMPACT OF HYPERTENSION ON MATERNAL OUTCOME IN WOMEN WITH COARCTATION OF THE AORTA	775
CORONARY BIFURCATION SIDE BRANCH LESIONS: DRUG-COATED BALLOONS VS. NON-COATED BALLOON ANGIOPLASTY	663
CAN THE PRESENCE OF BREAST ARTERIAL CALCIFICATION ON MAMMOGRAPHY INDICATE INCREASED RISK OF CORONARY ARTERY DISEASE? A SYSTEMIC REVIEW AND META-ANALYSIS	542
TAKAYASU'S ARTERITIS AS NON-TRADITIONAL RISK FACTOR FOR THE CARDIOVASCULAR DISORDERS - A POPULATION BASED STUDY	532
DEVELOPMENT AND VALIDATION OF AN OUTCOME PREDICTION MODEL FOR REPAIRED TETRALOGY OF FALLOT: THE INDICATOR COHORT	503
APPLICATION OF ACC/AHA 2020 HEART FAILURE CLINICAL PERFORMANCE AND QUALITY MEASURES FOR ADULTS WITH HEART FAILURE IN A MIDDLE-INCOME-NATION	466
ADULTS WITH DOWN SYNDROME: UPDATE ON SAFETY AND LONG-TERM OUTCOMES OF CARDIAC SURGERY AND PERCUTANEOUS INTERVENTIONS	461
PERCUTANEOUS CORONARY INTERVENTION OUTCOMES IN PATIENTS WITH LIVER CIRRHOSIS A META ANALYSIS	437
FULL COVER STENTING MAY WORSEN CLINICAL OUTCOME FOR THE TREATMENT OF FEMOROPOPLITEAL LESIONS INVOLVING DISTAL POPLITEAL ARTERY	422
THE IMPACT OF RACIAL DISPARITIES ON DIAGNOSIS AND TREATMENT OF PERIPHERAL ARTERY DISEASE	347
DOUBLE TROUBLE: NEW ONSET DYNAMIC LVOT OBSTRUCTION AFTER TAVR	340
CAUSE OF DEATH ANALYSIS IN PATIENTS WITH INTERMEDIATE RISK ACUTE PULMONARY EMBOLISM	328
CAUSE AND CIRCUMSTANCE OF VERY LATE STENT THROMBOSIS ASSESSED BY OPTICAL COHERENCE TOMOGRAPHY IN JAPANESE PATIENTS	312
LONG TERM EFFECTS OF SARS-COV-2 INFECTION ON CHILDREN'S VASCULATURE	304
A CASE OF WIDE COMPLEX TACHYCARDIA IN A PATIENT WITH PROPIONIC ACIDEMIA AND LONG QT SYNDROME	292
REPRESENTATION OF WOMEN AMONG CARDIOLOGY GRAND ROUNDS SPEAKERS AT ACADEMIC CENTERS IN THE UNITED STATES	275
THE IMPORTANCE OF EARLY RECOGNITION OF DELIRIUM IN PATIENTS UNDERGOING TRANSCATHETER AORTIC AND MITRAL VALVE REPLACEMENT	271
COMPARISON OF THREE-YEAR OUTCOMES OF DRUG-COATED BALLOON ANGIOPLASTY IN TOTALLY OCCLUSIVE VS. NON-OCCLUSIVE IN-STENT RESTENOSIS OF DRUG-ELUTING STENTS	264
PROPER USE OF CHRONIC TOTAL OCCLUSIONS (CTO) HYBRID ALGORITHM TO SECURE LEFT MAIN DISSECTION	224
CONGENITAL HEART DEFECTS AND THE SEVERITY OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER, A META-ANALYSIS.	222
“PAUSE AND EFFECT”: AN ADVERSE REACTION OF TICAGRELOR.	216
ECHOCARDIOGRAPHIC EPICARDIAL FAT THICKNESS AS A PREDICTOR FOR RECURRENCE OF PREGNANCY-INDUCED HYPERTENSION IN EGYPTIANS	214

IS SYSTOLIC AND DIASTOLIC FUNCTION INCLUDING GLOBAL LONGITUDINAL STRAIN BY ECHOCARDIOGRAPHY COMPROMISED IN ADULT PATIENTS TREATED WITH CD19 CAR T-CELL THERAPIES FOR HEMATOLOGICAL MALIGNANCIES IN THOSE	212
MYOCARDIAL FDG UPTAKE VARIATION AND ITS RELATIONSHIP WITH SURVIVAL DURING IMMUNOTHERAPY	211
GENDERED SOCIAL DETERMINANTS OF HEALTH AND RISK OF MAJOR ADVERSE OUTCOMES IN ATRIAL FIBRILLATION	209
AN EXPLORATORY STUDY OF EFFECTIVENESS AND SAFETY OF RIVAROXABAN IN PATIENTS WITH LEFT VENTRICULAR THROMBUS (R-DISSOLVE)	198
LONG-TERM OUTCOMES OF HEART TRANSPLANTATION AND LEFT VENTRICULAR ASSIST DEVICES IN PATIENTS LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS: A SYSTEMATIC REVIEW AND META-ANALYSIS	198
IMPACT OF GEOGRAPHICAL VARIATION BETWEEN EUROPE AND ASIA ON CLINICAL OUTCOMES IN PATIENTS WITH HIGH BLEEDING RISK (HBR) AND BIODEGRADABLE-POLYMER SIROLIMUSELUTING CORONARY STENT: A SUBSTUDY OF MASTER	197
EMBOLIZATION OF MECHANICAL AORTIC VALVE	197
IMPACT OF RACE ON CLINICAL OUTCOMES IN PATIENTS WITH SECONDARY MITRAL REGURGITATION: ANALYSIS FROM THE COAPT TRIAL	197
IMPACT OF THE $35 INSULIN PROGRAM ON OUT-OF-POCKET COSTS UNDER MEDICARE PART D	185
SHINGLE-VACCINE ASSOCIATED MYOCARDITIS-A CASE REPORT	183
SKIN DEEP BEFORE CHANGE OF HEART-MELANOMA CHECK POINT INHIBITOR INDUCED MYOCARDITIS	180
SEX DIFFERENCES IN OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT WITH NEWER GENERATION DEVICES: A META-ANALYSIS	180
PATIENT REPORTED OUTCOMES OF CATHETER ABLATION FOR ATRIAL FIBRILLATION IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION	180
EVERY ECHODENSE MASS IS NOT TISSUE- A CASE OF AN INTRA-CORONARY STENT PROTRUDING INTO THE AORTIC LUMEN	179
HEALTH STATUS PRESENTATION THRESHOLDS IN REAL-WORLD PERIPHERAL ARTERY DISEASE SPECIALTY CARE	179
DEMOGRAPHIC AND CLINICAL DETERMINANTS OF ISCHEMIC WORKUP IN PATIENTS WITH HEART FAILURE	172
THE EFFECTIVENESS AND FEASIBILITY OF USING MULTI-LEAD ECG MONITORING COMBINED WITH A PROGRAMMED INTRACAVITARY ECG TO COMPLETE LEFT BUNDLE BRANCH AREA PACING	172
RIGHT MASS, WRONG TIME: METASTATIC ECCRINE POROCARCINOMA TO THE RIGHT VENTRICLE	168
A NOVEL METHOD FOR IDENTIFYING DIFFUSE MYOCARDIAL ISCHEMIA DURING MENTAL STRESS PREDICTS RECURRENT HEART FAILURE IN INDIVIDUALS WITH RECENT MYOCARDIAL INFARCTION	167
NATIONAL TRENDS OF MECHANICAL SUPPORT UTILIZATION DURING PERCUTANEOUS CORONARY INTERVENTIONS IN CHRONIC TOTAL OCCLUSION	163
IMPACT OF CYTOCHROME 5 REDUCTASE 3 PARTIAL LOSS OF FUNCTION ON MAJOR ADVERSE CARDIOVASCULAR EVENTS IN BLACK ADULTS	163
SGLT2 INHIBITOR USE IN HFPEF ASSOCIATED WITH SEVERE SEPSIS AND SEPTIC SHOCK AND A NEW ONSET CARDIOMYOPATHY	163
CARDIOVASCULAR EVENTS IN PATIENTS WITH VTE: A COHORT STUDY IN REGION STOCKHOLM	162
TCTAP C-189 A Challenging Case Report: Transcatheter Occulsion One Coronary Artery Fistula From Right Coronary Artery to Left Ventricule	158
IS EXPOSURE TO EPSTEIN-BARR VIRUS A RISK FACTOR FOR LONG-COVID?	156
LVOT OBSTRUCTION AFTER SURGICAL AORTIC VALVE REPLACEMENT TREATED WITH ALCOHOL SEPTAL ABLATION	154
TCT-575 Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold: 24-Month Clinical Outcomes in First 100 Patients	152
TCTAP C-183 Device-Related Hemolytic Anemia After Transcatheter Closure of a Ruptured Ventricular Septum: To Wait or to Act?	151
TCTAP C-059 A Hard Decision and the Only Option : Provisional LM Stenting in Very Calcified Vessel	148
TCT-247 Hemodynamic Comparison of Resilia and Sapien 3/Ultra Transcatheter Heart Valves in Transcatheter Aortic Valve Replacement	147
A COMBINED APPROACH USING HIGH-SENSITIVE TROPONIN I AND N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE FOR RISK STRATIFICATION IN PATIENTS WITH CORONAVIRUS DISEASE 2019	147
Association Between High-Sensitivity Cardiac Troponin, Myocardial Ischemia, and Revascularization in Stable Coronary Artery Disease	146
TCT-189 The Efficacy and Safety of an Adjunctive Transcoronary Pacing Strategy During Rotational Atherectomy: The Results of the Strategy to Rotablate and PACE (ROTA-PACE) Study	145
PRIMARY TRICUSPID REGURGITATION AND PATENT FORAMEN OVALE: A RARE CAUSE OF HYPOXEMIA	134
CARDIAC MASS IN A PATIENT WITH RELAPSING CHRONIC LYMPHOCYTIC LEUKEMIA WITH NONDIFFUSE BONE MARROW INVOLVEMENT	133
EFFICACY OF TRANSCATHETER INTERATRIAL SHUNT DEVICES IN HEART FAILURE: A SYSTEMATIC REVIEW AND META-ANALYSIS	132
A BABY SO ADORABLE MY HEART CANTU HELP BUT STOP: A CASE OF PERIPARTUM COMPLETE HEART BLOCK WITH GENETIC PREDISPOSITION	131
Contents	131
TCT-127 Medical Therapy Versus Early Revascularization in Diabetics With Chronic Total Occlusion of Coronary Arteries: A Meta-analysis and Systematic Review	129
Audio Summary	128
PERSISTENT BLOODY DIARRHEA IN A HEART TRANSPLANT PATIENT	127
CORONARY FLOW RESERVE AND STRESS MYOCARDIAL BLOOD FLOW ACROSS THE SPECTRUM OF AORTIC STENOSIS	127
CARDIAC AMYLOIDOSIS- A WOLF IN SHEEP'S SKIN	126
METHYLMALONIC ACIDEMIA: A RARE CAUSE OF REVERSIBLE DILATED SYSTOLIC HEART FAILURE	125
IS SACUBITRIL/VALSARTAN LESS LIKELY TO BE PRESCRIBED IN ELDERLY PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION? A ROOT CAUSE ANALYSIS	125
A MIMICKER OF CONSTRICTION: A RARE CASE OF CARDIAC ANGIOSARCOMA	125
ASSOCIATION OF AGE WITH ORAL ANTICOAGULANT PRESCRIPTION AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION: INSIGHTS FROM A UNITED STATES COMMERCIAL CLAIMS DATABASE	121
HEART FAILURE IS ASSOCIATED WITH INCREASED ALL-CAUSE MORTALITY IN TRANSVENOUS LEAD EXTRACTION: A SYSTEMATIC REVIEW AND META-ANALYSIS	120
TRANSVENOUS ICD IN A PATIENT WITH PULSATILE BIDIRECTIONAL GLENN REPAIR AND BIOPROSTHETIC PULMONARY VALVE	120
TCT-570 Deep Learning-Enabled Assessment of Right Ventricular Function Using 2D Echocardiograms Improves 1-Year Mortality Prediction in Patients With Severe Mitral Regurgitation Undergoing Transcathet	119

MECHANISM OF EFFORT INTOLERANCE IN HYPERTROPHIC CARDIOMYOPATHY: COMBINED STRESS ECHOCARDIOGRAPHY & CARDIOPULMONARY EXERCISE TEST	118
SPONTANEOUS CORONARY ARTERY DISSECTION IS A RARE CASE OF ARRHYTHMIAS.	117
TCT-463 Microcirculatory Status After Intravascular Lithotripsy: The Marvel Study	117
METABOLIC SIGNATURES OF CARDIAC DYSFUNCTION ARE ASSOCIATED WITH MULTIMORBIDITY AND POST-TRANSCATHETER AORTIC VALVE IMPLANTATION MORTALITY	114
SEVERE PULMONARY HYPERTENSION FOLLOWING CORONAVIRUS-19 INFECTION IN A PATIENT WITH PRIOR SPLENECTOMY	113
SGLT2i and Deterioration of Kidney Function in Heart Failure	110
Understanding the Transplant Recipient Implications of Hearts From Donors With Active COVID-19	110
INFORMING RESEARCH TO PRACTICE TRANSLATION OF TELEMEDICINE MANAGEMENT OF HYPERTENSION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL TRIALS	108
THE PREVALENCE OF NORMAL CORONARY ARTERIES AS DETERMINED BY A CORONARY ARTERY CALCIUM SCORE OF ZERO AMONGST SUBJECTS WITH DIABETES MELLITUS	108
ALLERGIC HEART: EPINEPHRINE-INDUCED KOUNIS SYNDROME	107
LEFT VENTRICULAR DIASTOLIC DYSFUNCTION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: 1-YEAR EFFICACY AND MORTALITY OUTCOMES	107
SPONTANEOUS CORONARY ARTERY DISSECTION AS AN ISOLATED MANIFESTATION OF FIBRILLIN-1 MUTATION.	106
HOSPITAL VOLUME-OUTCOME RELATIONSHIP OF BALLOON PULMONARY ANGIOPLASTY AND PULMONARY THROMBOENDARTERECTOMY FOR CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	105
RENOVASCULAR HYPERTENSION ASSOCIATED WITH RADIATION-INDUCED ABDOMINAL AORTIC STENOSIS AFTER RENAL AUTOTRANSPLANTATION	105
SERIAL 3D PRINTING TO PLAN A STAGED PALLIATION IN A PATIENT WITH COMPLEX CONGENITAL HEART DISEASE AND MAJOR AORTOPULMONARY COLLATERALS	105
ASSOCIATION OF PROGNOSTIC NUTRITIONAL INDEX AND DIABETES WITH PROGNOSIS OF CORONARY ARTERY DISEASE	104
HEARTBREAK AT THE PIRATES GAME: PERCUTANEOUS EXTRACORPOREAL LIFE SUPPORT AS A RESCUE THERAPY IN ACUTE MYOCARDIAL INFARCTION COMPLICATED BY OUT-OF-HOSPITAL CARDIAC ARREST	103
TCTAP C-160 Optical Coherence Tomography Guided Percutaneous Coronary Intervention of Spontaneous Recanalized Coronary Thrombus	103
TCT-446 Thou Shall Pass! A Modified Technique With 100% Successful First-Attempt Crossover From IVC to Aorta in Transcaval TAVR	101
IMPACT AND ASSOCIATED FACTORS ON MITRAL REGURGITATION SEVERITY IN ATRIAL FIBRILLATION PATIENTS AFTER CATHETER PULMONARY VEIN ISOLATION	101
TCT-307 In Vivo Characterization of Coronary Plaques: Findings From a Novel Hybrid Intravascular Ultrasound-Optical Coherence Tomography Intracoronary Imaging System	101
THE EFFECTS OF EMPAGLIFLOZIN AND ORAL KETONE ESTER ON CARDIAC FUNCTION, STRUCTURE, AND METABOLISM IN HEART FAILURE WITH PRESERVED EJECTION FRACTION	101
MANAGEMENT DECISIONS FOR THE ADULT PATIENT WITH A LARGE DUCTUS ARTERIOSUS AND DIFFERENTIAL CYANOSIS: WHEN LOCATION MATTERS!	101
Contents	98
PATTERNS AND GAPS IN GUIDELINE-DIRECTED STATIN USE FOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN DISAGGREGATED HISPANIC AND ASIAN SUBGROUPS	97
TCTAP A-001 Prediction Model for In-Stent Restenosis After Carotid Artery Angioplasty and Stenting	96
Contents	96
TCT-290 Relationship Between Cardiac Computed Tomography-Derived Coronary Artery Volume and Myocardial Mass in Severe Coronary Artery Disease Population	96
TCT-723 Urgent TEER in 5,428 Patients With Severe Mitral Regurgitation and Cardiogenic Shock: A Systematic Review and Meta-Analysis	95
TCT-199 A Symptom-Stratified Analysis of the Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina Trial	95
TCT-530 Short-Term Structural Remodeling Following Bicaval TricValve Implantation for Treating Severe Tricuspid Regurgitation	95
TCT-468 Outcomes of Early Coronary Reperfusion After Resuscitated Out-of-Hospital Cardiac Arrest	94
TCTAP A-042 An Umbrella Review of the Meta Analyses About Risk and Protective Factors for Post-discharge Bleeding Events in Percutaneous Coronary Intervention Setting	94
TCTAP C-180 Atrial Septal Defect With Desaturation in an Elderly Patient : Need to Closed	94
TCTAP C-139 A Unique Case of in Stents Restenosis: The Rings of Fire	93
EDOXABAN 30 MG VS WARFARIN IN 2,406 PATIENTS AGE ≥80 YEARS: A RANDOMIZED ANALYSIS FROM ENGAGE AF-TIMI 48	92
TCTAP A-086 Can a Machine Learning Based Approach Improve Risk Prediction and Individualise Decision Making Between Percutaneous and Surgical Revascularisation in Patients With Complex Coronary Artery	92
TCTAP A-039 On-Pump and Off-Pump Coronary Artery Bypass Grafting on 10-Year Mortality Versus Percutaneous Coronary Intervention	92
PATIENT-REPORTED OUTCOMES IN CLINICAL STUDIES OF PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICES	91
TREATMENT WITH CILOSTAZOL IMPROVES SYMPTOM SCORES AND LOWERS PULMONARY ARTERY DIASTOLIC PRESSURE IN HFPEF PRELIMINARY RESULTS FROM THE CLIP-HFPEF N-OF-1 STUDY	91
TCT-303 The Role of Quantitative Calcific Assessment in Prognosis of Procedural Events in TAVR	90
Audio Summary	90
TCT-157 Sirolimus-Coated Balloon in Femoropopliteal Steno-Occlusive Disease: Efficacy, Safety, and 1-Year Outcomes—An All-Comers Registry	89
TCTAP C-099 Double Trouble ! Coronary Dissection by Balloon Rupture Followed by Stuck IVUS After Stenting in a Rotational Atherectomy Case	88
TCT-752 Combined Valvular and Subvalvular Intervention With Innovalve TMVR Facilitates Reverse Remodeling and Improves Left Ventricular Ejection Fraction in Patients With Severe Chronic Mitral Regurgi	88
TCT-731 Long-Term Outcome of Left Main PCI According to Stenting Technique: 15-Year Real-World Single-Center Experience	87
TCT-17 Cross-Sectional Analysis of Disparities and Excess Vascular Mortality Associated With the COVID-19 Pandemic	87
TCT-229 Effect of Delayed Hospitalization on Patients With Non–ST-Segment Elevation Myocardial Infarction and Complex Lesions Undergoing Successful New-Generation Drug-Eluting Stent Implantation	87
TCTAP C-096 When a Stent Was Left Behind..	87
CARDIAC SEQUELAE OF LONG-COVID	86
BRADYCARDIA INDUCED TORSADES AND VT STORM, A WILD GOOSE CHASE	86
PACED QRS WIDTH IS ASSOCIATED WITH PACING-INDUCED CARDIOMYOPATHY IN PATIENTS RECEIVING LEADLESS PACEMAKERS: A MULTICENTER RETROSPECTIVE STUDY	86
TCTAP C-142 A Challenging Case of Simultaneous Transarterial Coil Embolization in the Treatment of Post-EVAR Endoleak	85
TCT-403 Transcatheter Aortic Valve-in-Valve Replacement for Failing Sutureless Aortic Valves	85
TCT-161 Coronary Lipid Burden Early After Heart Transplantation as Assessed by Optical Coherence Tomography	84
A RARE CASE OF CHONDROSARCOMA WITH CARDIAC METASTASIS	84
TCT-338 “Tip in/Rendez-vous” Technique in Retrograde Chronic Total Occlusion Percutaneous Coronary Interventions: Insights From the PROGRESS CTO Registry	84
IMPACT OF RELATIVE TEE GASTROESOPHAGEAL CONTRAINDICATIONS ON OUTCOMES IN HOSPITALIZATION UNDERGOING TEE	84
Reaching for the Stars With the Least Number of Interventions Possible	84
TCT-405 Predictive Computational Modeling of THV Under-Expansion and Late Balloon Aortic Valvuloplasty to Treat THV Dysfunction	83
TCT-465 Abstract Withdrawn	83
IS MYOCARDIAL BRIDGING A BENIGN EVENT?	83
TCT-507 Coronary Access After TAV-in-TAV Procedure in Asian Cohort: A Single-Center Simulation Study	82
THE EFFECTS OF ELECTRICAL MICROCURRENT TREATMENT ON MYOFIBROBLAST	80
SEA ANEMONE TUMOR OF THE AORTA PRESENTING WITH DYSPNEA IN A WOMAN	79
TCT-567 Abstract Withdrawn	79
TCT-90 Predictors of Device-Related Complications in Elderly Patients Requiring Mechanical Circulatory Support for Cardiogenic Shock Due to Acute Coronary Syndrome	78
COMPARISON AND RELIABILITY OF QT MEASUREMENTS GENERATED BY EKG MACHINES	77
SYMPTOMATIC HEMOLYTIC ANEMIA FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT DUE TO DELAYED PARAVALVULAR LEAK MANAGED WITH BALLOON POSTDILATION	77
Another Road to Rome	77
TCT-770 Women Undergoing High-Risk PCI Have Better 12-Month Survival Despite Higher Complexity of Coronary Artery Disease: Insights From the IMPELLA-PL Registry	77
TCTAP C-077 Antegrade Approach Strategy for Left Main CTO Lesion	76
SPONTANEOUS THROMBOSIS OF NATIVE RHEUMATIC MITRAL VALVE PRESENTING AS A STROKE	76
GENDER DISPARITY IN CLINICAL OUTCOMES IN PATIENTS WITH TAKOTSUBO CARDIOMYOPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS.	75
TCT-218 Influence of Target Lesion Locations on Clinical Outcomes After Endovascular Therapy in Patients With Peripheral Artery Disease	75
TCT-15 National Trends, In-Hospital Mortality, and Outcomes of Atrial Septal Defect/Patent Foramen Ovale Closure Procedure: An Analysis From the National Inpatient Sample	75
TCT-452 Predictors of Prolonged Hospitalization After Transcatheter Aortic Valve Implantation	75
TCT-517 Optimal Minimal Stent Area Criteria for Long-Term Clinical Outcomes in Provisional Simple Cross-over Stenting for Left Main Bifurcation Stenosis	75
TCT-758 Clinical Outcomes of COVID-19 In Patients With Heart Failure With Reduced Ejection Fraction: Insights From National Inpatient Sample Database	75
TCT-181 Effect of Lipoprotein(a) in Patients With Coronary Calcification Undergoing Percutaneous Coronary Intervention	75

Dawn of the Era of Individualized Genetic Profiling in the Prevention of Sudden Cardiac Death	74
TCT-911 A Novel Automated and Portable Carbon Dioxide Angiographic Injector for Peripheral Endovascular Therapies in Patients at High Risk of Iodinated Contrast Media	74
TCT-477 Household Income and Readmissions After TAVR	74
TCT-1082 Impact of Weekend Admission on Outcomes in STEMI Patients Undergoing Early Percutaneous Coronary Intervention: A National Retrospective Cohort Study	74
TCT-42 Incidence and In-Hospital Outcomes of Bradycardia or Atrioventricular Conduction Disorder in Patients with Type 2 Myocardial Infarction: A Nationwide Inpatient Analysis	73
TCT-714 Final Results from the US Pivotal Study of the Vivasure PerQseal® System for Large Hole Closure: PATCH	73
TCT-1270 Impact of Frailty on Patients Undergoing TEER MitraClip With Underlying Hypertrophic Cardiomyopathy	71
TCT-1226 Valve-in-Valve TAVR for Failed Trifecta Surgical Bioprosthetic Aortic Valves	71
TCT-34 Optimal Duration of Oral Sildenafil for Perioperative Management of Severe Pulmonary Hypertension in Mitral Valve Replacement: A Comparative Cross-Sectional Study	71
TCT-37 Impact of LVEF on Baseline Characteristics and Outcomes in TTVR Recipients	70
TCT-939 Deep Learning Analysis of MIMIC-IV Waveform Data for Predicting Adverse Events Following Percutaneous Coronary Intervention	70
TCT-1177 Early Outcomes of Transcatheter Self-Expandable Valves (SEV) in SEV Versus Balloon-Expandable Valves (BEV) in SEV	70
TCT-122 Cardiovascular Outcomes of Transcatheter Aortic Valve Replacement and Atrial Fibrillation With Versus Without Direct Oral Anticoagulation (DOAC)	70
TCT-203 AI-Powered ECG Interpretation Enables Earlier STEMI Identification and Reduces False-Positive Activations in a U.S. Multicenter Registry	69
TCT-1061 Comparative Effectiveness of a Novel Scatter Radiation Shielding System Versus Standard Shielding	69
TCT-701 Suboptimal Stenting Results and Long-Term Outcomes After Intravascular Ultrasound-Guided PCI	69
TCT-638 Impact of End-Stage Renal Disease on Short- and Mid-Term Outcomes After Mitral Transcatheter Edge-to-Edge Repair	69
TCT-770 Clinical Outcomes of Combined RAAS Inhibitor and Statin Therapy in Patients Undergoing Transcatheter Aortic Valve Replacement: A Large-Scale Propensity-Matched Analysis	69
TCT-260 Multivessel Versus Culprit-Vessel Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction with Cardiogenic Shock	69
TCT-875 Parametric Finite Element Modeling of Reinforced Polymeric Leaflets for Improved Durability	69
TCT-863 Clinical Profile and Outcomes of Patients Deemed Ineligible for Transcatheter Tricuspid Valve Intervention	68
TCT-850 The Continuous Saline Infusion Rate Required to Achieve Maximal Hyperaemia for Catheter-Based Measurements of Absolute Coronary Blood Flow and Microcirculatory Resistance in Severe Aortic Sten	68
TCT-1250 Thin-cap fibroatheroma is the only type of coronary plaque associated with high vulnerability despite absence of ischemia: insights from a patient level pooled analysis of COMBINE (OCT-FFR) a	68
TCT-1107 Clinician Perceptions on Shared Decision Making for Patients with Severe Aortic Stenosis	68
TCT-1203 Sex Inequities in Cardiac Rehabilitation After Acute Coronary Syndrome: A Systematic Review of Clinical and Functional Outcomes	68
TCT-633 Trends and In-Hospital Outcomes of Transcatheter Edge-to-Edge Repair (TEER) in Patients with Atrial Arrhythmias and Chronic Inflammatory Diseases: A Nationwide Analysis	67
TCT-653 Angiography-derived physiological patterns of Coronary Artery Lesion and Angina status in the context of functional revascularization completeness, optimal hemodynamic post-PCI and absence of	67
TCT-148 Intravascular Lithotripsy in Real-World Calcified Coronary Lesions: Insights from the GISE Shockcalcium Registry	67
TCT-295 Surgical Left Atrial Appendage Occlusion During Cardiac Surgery in Atrial Fibrillation: A Contemporary Systematic Review and Meta-Analysis	67
TCT-47 Eliminating the Substrate, Eliminating the Risk: A Single-Arm Meta-Analysis of Catheter Ablation in Brugada Syndrome	66
TCT-342 Real-Time IVUS-Guided Wiring Using Conventional Pull-Back Systems in Blunt Cap CTO PCI: A Feasible and Effective Strategy	66
TCT-227 Routine Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials	65
TCT-223 Hemodynamic and Clinical Outcomes of Transcatheter Valve Expansion in Degenerated Mitral Bioprostheses	65
TCT-811 Myocardial Bridge Evaluation Towards Personalised Medicine: the RIALTO registry	65
TCT-321 Cerebral Embolic Protection Devices in Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials	65
TCT-845 Impact of Cerebral Embolic Protection on Perioperative Stroke in TAVR for Patients With Atrial Fibrillation	64
TCT-510 Real-World Usage of a Prevail Paclitaxel-Coated Balloon Compared With Other Contemporary Drug-Coated Balloons for Long Coronary Artery Lesions	64
TCT-200 Artificial Intelligence Detection of Retrograde Coronary Flow	64
TCT-603 Performance of Aortic Valve Coefficient (AVC) in Relation with Calcium Score (CS) and Aortic Valve Area (AVA) in Patients Undergoing TAVR	64
TCT-583 Influence of Heparin-Induced Thrombocytopenia on In-Hospital Outcomes in Patients With Left Ventricular Assist Devices (LVAD): A Decade-Long Study	63
TCT-395 Differences in Outcomes Between Rutherford 4 and Rutherford 5/6 Patients Undergoing Endovascular Intervention for Lower Extremity Peripheral Artery Disease	63
TCT-480 Blood Pressure Reductions by Radiofrequency Renal Denervation Procedural Characteristics: Pooled 24-Month Results From the SYMPLICITY Clinical Program	63
TCT-39 Comparison of Clinical Outcomes Among Balloon Angioplasty, Drug-Coated Balloon, and the Second or Newer Drug-Eluting Stent	63
TCT-620 Employment of Artificial Intelligence for an Unbiased Evaluation Regarding the Recovery of Right Ventricular Function After Mitral Valve Transcatheter Edge-to-Edge Repair	63
TCT-442 Tissue Characteristics Can Predict Clinical Outcome in Stent-Less Percutaneous Coronary Intervention With Directional Coronary Atherectomy Followed by Drug-Coated Balloon: Insights From Histol	63
TCT-247 Long-Term Follow-Up of Angiographically Intermediate but Hemodynamically Nonsignificant Lesions	62
Audio Summary	62
TCT-990 Coronary Artery Calcium and Cardiovascular Risk Factors Analysis After Radiotherapy for Breast Cancer: The CLARIFIER: A Gender-Based Preventive Medicine Study	62
TCT-949 Long-Term Mechanical Durability of Surgical Aortic Valves: A 2 Billion Cycle In Vitro Study	62
TCT-251 Practice Patterns and Percutaneous Coronary Intervention Outcomes in University Hospitals: A Comparison Between Sweden and the U.S.	62
TCT-471 Sex-Specific Predictors of Adverse Events in Patients Treated With Advanced Mechanical Circulatory Support	62
TCT-705 Comparative Outcomes of Endovascular Intervention Versus Bypass Surgery for Peripheral Artery Disease in Patients With Atrial Fibrillation: A Retrospective Analysis of the National Inpatient S	62
TCT-493 Drug-Coated Balloon Angioplasty vs Plain Balloon Angioplasty in Patients With Coronary In-Stent Restenosis: A Meta-Analysis of Randomized Controlled Trials	62
TCT-533 Retrospective Comparison of Device Utilization for Left Atrial Appendage Occlusion: Amulet vs. Watchman	61
TCT-403 Intravascular Ultrasound Findings Associated With Hydrodynamic Contrast Recanalization of Coronary Chronic Total Occlusions	61
TCT-136 We Tested a Novel CT-Guided Algorithm for Transcatheter Aortic Valve Implantation Sizing and Placement in Patients With Severe Bicuspid Aortic Stenosis Incorporating Both Downsizing and Supra-	61
TCT-163 Self-Expandable vs Balloon-Expandable Valves in Patients With Small Annuli Undergoing Transfemoral Transcatheter Aortic Valve Implantation	61
TCT-151 First-in-Human Study of Novel Cerebral Protection in TAVR: An Alternative to Filter-Based Protection	61
TCT-661 Use of Post–Percutaneous Coronary Intervention Non-hyperemic Pressure Ratios to Guide Procedural Optimization: Cautions and Caveats	60
TCT-269 Insights From the Danger-SHOCK and ECLS-Shock Trials: A Comparative Analysis	60
TCT-873 Biomechanical Analysis of the J-Valve Bioprosthesis: A Computed tomography–Based Computational Study	60
TCT-509 Predictors of Stent Under Expansion in the CALIPSO Trial	60
TCT-824 Transcatheter Aortic Valve Implantation on Coronary Guidewires: Free-Contrast Technique in Patients With Moderate to Severe Renal Impairment	60
TCT-64 Left Atrial Appendage Closure: What Is Fabric Edge Leak and How to Treat it?	60
TCT-183 Periprocedural Continuation vs Interruption of Oral Anticoagulation During Transcatheter Aortic Valve Implantation: Effect on Plasmatic Coagulation and Fibrinolysis	60
TCT-911 Vascular Disease in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: From Incidence to Clinical Outcomes	60
TCT-112 Association Between Residual Shunt and the Endothelialization of the Closure Devices for Patent Foramen Ovale (PFO) 12 Months After Implantation Evaluated by Angioscopy	60
TCT-419 Comparative Clinical Outcomes of Amphilimus-Eluting Stents in Diabetic vs Nondiabetic Patients	60
TCT-819 Impact of Sodium-Glucose Co-Transporter Inhibitors on Cardiovascular Outcomes in Patients With Acute Myocardial Infarction: A Systematic Review and Meta-Analysis	60
TCT-290 Survival After PCI or CABG in Patients With NSTEMI and Left Main Disease: A Report From the Registry	59
Bioprosthetic Aortic Valve Hemodynamics: Definitions, Outcomes, and Evidence Gaps	59
Worldwide Chronic Retrieval Experience of Helix-Fixation Leadless Cardiac Pacemakers	59
2025 Acute Coronary Syndromes Guideline-at-a-Glance	59
TCT-326 Outcomes of Acute Kidney Injury and Hemodialysis Use in Acute Pulmonary Embolism	59
Choosing Between CABG and PCI for 3-Vessel Coronary Disease	59
Dyslipidemia in Human Immunodeficiency Virus Disease	59
Long-Term Lessons From the COACT Trial	58
Cardiac Arrest and Sudden Death	58
Return-to-Play for Elite Athletes With Genetic Heart Diseases Predisposing to Sudden Cardiac Death	58
Correction	58
Central Adiposity or Hypertension	57
26-A-22913-ACC EDUCATIONAL DISPARITIES AND CARDIOVASCULAR RISK: INSIGHTS FROM THE HEARTBEAT STUDY	57
Quality of Life After Percutaneous Coronary Intervention or Medical Therapy for Chronic Total Coronary Occlusions	57
26-A-17220-ACC IMPACT OF CHRONIC KIDNEY DISEASE ON THE SAFETY AND EFFICACY OF PULSED-FIELD ABLATION FOR ATRIAL FIBRILLATION	56
26-CCC-7526-ACC TURNING OFF THE TAP: RESOLUTION OF HIGH-OUTPUT HEART FAILURE AND PERSISTENT ATRIAL FIBRILLATION AFTER RENAL ARTERIOVENOUS MALFORMATION RESECTION VIA NEPHRECTOMY	55
26-A-16351-ACC THE EFFECTIVENESS OF NO OR LOW-DOSE VERSUS HIGH-DOSE ASPIRIN IN ACUTE KAWASAKI DISEASE: AN UPDATED META-ANALYSIS	55
26-CCC-18053-ACC HISTOPATHOLOGICAL DIAGNOSIS OF SYSTEMIC AMYLOIDOSIS: THE DECISIVE ROLE OF CARDIAC BIOPSY	55
26-A-13778-ACC SINGLE ANTIPLATELET THERAPY VERSUS DOAC MONOTHERAPY IN SPONTANEOUS CORONARY ARTERY DISSECTION: A 30-DAY PROPENSITY-MATCHED ANALYSIS FROM THE TRINETX NETWORK	55
26-A-16842-ACC REAL WORLD IMPACT OF TIRZEPATIDE ON CLASS III OBESE PATIENTS UNDERGOING ATRIAL FIBRILLATION ABLATION	55
26-A-15846-ACC INDEPENDENT ASSOCIATION BETWEEN LIPOPROTEIN(A) AND ATRIAL FIBRILLATION/FLUTTER: INSIGHTS FROM A REAL-WORLD COHORT	55
26-A-16975-ACC UNDERSTANDING THE IMPACT OF ATRIAL FIBRILLATION HISTORY ON RAPID RESPONSES WITHIN 24 HOURS OF ADMISSION	54
26-A-15320-ACC ELECTRONIC NUDGES FOR GUIDELINE-DIRECTED MEDICAL THERAPY IN CHRONIC KIDNEY DISEASE: LONG-TERM FOLLOW-UP OF FACTORIAL RANDOMIZED IMPLEMENTATION TRIAL	54
26-A-11220-ACC CLINICAL COMPARISON OF AI TOOLS TO GUIDE 99MTC-PYP REFERRAL FOR CARDIAC AMYLOIDOSIS	54
26-CCC-13480-ACC THE INFECTED ATRIUM: LEFT ATRIAL MYCOTIC ANEURYSM AS A RARE COMPLICATION OF MITRAL VALVE ENDOCARDITIS	54
26-A-11020-ACC FROM WASTE TO WORTH: RECYCLING TO REDUCE THE ENVIRONMENTAL IMPACT OF CARDIAC PROCEDURES	54